Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment Outcome-Reference-Cited by-同舟云学术

Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment Outcome

Published:1994-03 Issue:3 Volume:151 Page:640-645
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Zietman A.L.¹,Coen J.J.¹,Shipley W.U.¹,Willett C.G.¹,Efird J.T.¹

Affiliation:

1. From the Department of Radiation Oncology, Genito-Urinary Oncology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. The value of serum prostate specific antigen determinations before and after radical prostatectomy;Lange;J. Urol.,1989

2. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients;Stamey;J. Urol.,1989

3. Clinical use of prostate specific antigen in patients with prostate cancer;Hudson;J. Urol.,1989

4. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia;Partin;J. Urol.,1990

5. Serum prostate-specific antigen: the most useful tumor marker;Andriole;J. Clin. Oncol.,1992

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer;Target Volume Definition in Radiation Oncology;2023

2. Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer;PLOS ONE;2021-03-12

3. Prostate cancer high dose-rate brachytherapy: review of evidence and current perspectives;Expert Review of Medical Devices;2017-12-22

4. Delineation of the Prostate Bed: The “Invisible Target” Is Still an Issue?;Frontiers in Oncology;2017-05-31

5. Prostate Cancer;Clinical Radiation Oncology;2016